CS
NLSPW

Clear Street’s NLS Pharmaceutics Warrant NLSPW Stock Holding History

Clear Street’s Portfolio NLSPW Stock Details NLSPW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-57,762
Closed -$1.03K – 979
2025
Q3 		$1.03K Hold
57,762
– – ﹤0.01% 775
2025
Q2 		$1.16K Buy
57,762
+120
+0.2% +$2 ﹤0.01% 606
2025
Q1 		$744 Sell
57,642
-300
-0.5% -$4 ﹤0.01% 503
2024
Q4 		$753 Buy
57,942
+49,700
+603% +$606 ﹤0.01% 504
2024
Q3 		$94 Sell
8,242
-29
-0.4% -$1 ﹤0.01% 664
2024
Q2 		$285 Sell
8,271
-306
-4% -$10 ﹤0.01% 717
2024
Q1 		$420 Buy
8,577
+77
+0.9% +$4 ﹤0.01% 694
2023
Q4 		$477 Sell
8,500
-100
-1% -$10 ﹤0.01% 695
2023
Q3 		$905 Hold
8,600
– – ﹤0.01% 897
2023
Q2 		$920 Hold
8,600
– – ﹤0.01% 1080
2023
Q1 		$1.29K Buy
+8,600
New +$1.42K ﹤0.01% 922

Clear Street's NLSPW Position: Q4 2025 in Review

Clear Street sold out of NLS Pharmaceutics Warrant (NLSPW) in Q4 2025, closing a stake of 57,762 shares — an estimated $1.03K sold.

Clear Street first reported a position in NLSPW in Q1 2023 and held it in 11 quarters. The position peaked at $1.29K in Q1 2023. 0 funds tracked by Wall St. Rank hold NLSPW as of Q4 2025.

  • Clear Street reported no remaining NLS Pharmaceutics Warrant position as of Q4 2025 after selling out during the quarter.
  • Clear Street sold 57,762 NLS Pharmaceutics Warrant shares in Q4 2025, an estimated $1.03K.
  • Clear Street first reported a position in NLS Pharmaceutics Warrant in Q1 2023 and held it in 11 quarters.
  • Clear Street's NLS Pharmaceutics Warrant position peaked at $1.29K in Q1 2023.
  • 0 funds tracked by Wall St. Rank held NLS Pharmaceutics Warrant as of Q4 2025.

Based on Clear Street's 13F filing for Q4 2025, filed 13 Feb 2026.